Can menopause cause joint pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Can Menopause Cause Joint Pain?

Yes, menopause can directly cause joint pain—this is a recognized menopausal symptom that affects more than half of women during the menopausal transition and is linked to declining estrogen levels. 1

The Evidence for Menopause-Related Joint Pain

Joint pain (arthralgia) is one of the most common symptoms reported during menopause, with prevalence rates exceeding 60-70% in multiple studies 2, 3. This is not coincidental timing—the evidence strongly suggests a causal relationship:

  • Hormonal mechanism: The menopausal transition itself is independently associated with increased joint pain, even after controlling for age, obesity, and other factors 4. Women experience increased aches, joint pain, and stiffness specifically during the menopausal transition (p<0.001), and within-woman fluctuations in estradiol levels correlate with these symptoms 4.

  • Clinical trial evidence: The Women's Health Initiative (WHI) demonstrated that estrogen-progestogen therapy (EPT) significantly improved joint pain or stiffness and general aches in postmenopausal women 1. Importantly, joint pain increased after discontinuation of hormone therapy, further supporting the hormonal connection 1.

  • Timing patterns: Joint pain prevalence peaks during early menopause and typically declines postmenopause, following the trajectory of hormonal changes 5. This temporal relationship strengthens the causal link.

What Makes This Different from Regular Arthritis?

This is a critical distinction for your patient to understand:

  • Menopausal arthralgia is not necessarily osteoarthritis: Studies show that reported joint symptoms in menopausal women are not strongly correlated with radiological evidence of osteoarthritis 6. While knee OA showed some association with symptoms, hand OA did not 6.

  • The syndrome is distinct: Similar joint pain syndromes occur with sudden estrogen withdrawal—whether from stopping hormone therapy or from aromatase inhibitor treatment in breast cancer patients 2. This reproducible pattern across different contexts of estrogen deprivation confirms the hormonal etiology.

Key Risk Factors to Assess

Your patient should know that certain factors worsen menopausal joint pain:

  • Smoking: Independently doubles the risk of moderate-to-severe joint pain (OR 2.18) through anti-estrogenic effects 7
  • Higher BMI: Significantly associated with increased joint symptoms 6, 4
  • Vasomotor symptoms: Strong association with severe joint pain (OR 6.16), suggesting shared hormonal mechanisms 3
  • Psychological factors: Depression, negative mood, and perceived stress all amplify joint pain reporting 6, 4
  • Premature menopause: Associated with increased risk (OR 1.58) 3

Treatment Approach

For women with bothersome menopausal joint pain who also have vasomotor symptoms, menopausal hormone therapy (MHT) is the most effective treatment and should be considered if they are under age 60 or within 10 years of menopause onset 1. The Endocrine Society guidelines explicitly recognize arthralgia as a treatable menopausal symptom 1.

However, the evidence for HRT specifically for isolated joint pain (without hot flashes) remains mixed 8, so the decision should weigh:

  • Presence of other menopausal symptoms (hot flashes, sleep disruption, mood changes)
  • Cardiovascular and breast cancer risk profile
  • Severity of joint pain impact on quality of life
  • Patient preference after informed discussion

Non-Hormonal Management

For women who cannot or prefer not to use MHT:

  • Exercise and weight management: Consistently show functional benefits across pain domains 5
  • Simple analgesia: Appropriate for symptom control 2
  • Address contributing factors: Treat concurrent sleep disturbance, depression, and fatigue—all of which amplify pain perception 2, 5
  • Smoking cessation: Modifiable risk factor with clear impact 7

Important Caveats

  • Always exclude other causes of joint pain: thyroid disorders, rheumatoid arthritis, other inflammatory conditions, or medication side effects 9
  • The relationship between reproductive hormones and osteoarthritis development is complex and not fully understood 10
  • Not all joint pain at menopause is "menopausal arthralgia"—concurrent osteoarthritis or other conditions may coexist 6

The bottom line: Reassure your patient that menopausal joint pain is real, common, and hormonally mediated—not "all in her head" or simply aging. Treatment options exist, particularly if she has other menopausal symptoms warranting hormone therapy.

References

1
Guideline

treatment of symptoms of the menopause: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2015

6
Research

The relationship of reports of aches and joint pains to the menopausal transition: a longitudinal study.

Climacteric : the journal of the International Menopause Society, 2008

7
Research

The association between smoking and joint pain in women attending a specialized menopause clinic.

Climacteric : the journal of the International Menopause Society, 2026

9
Guideline

american association of clinical endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2011

Related Questions

In a perimenopausal woman on combined estrogen‑progestogen therapy with lower‑extremity edema and cramps, does hypocalcaemia or hypercalcaemia more commonly cause muscle cramps?
Is an estrogen patch effective for treating leg pain?
What are the recommended treatments for menopausal myalgia?
In a postmenopausal woman on hormone therapy with diffuse musculoskeletal pain, is it appropriate to start gabapentin at bedtime and/or duloxetine (Cymbalta)?
What is the recommended evaluation and management for a 45‑55‑year‑old post‑menopausal woman presenting with musculoskeletal syndrome of menopause (joint and muscle aches, bone loss, and increased fracture risk)?
Could the horizontal nystagmus be due to an epileptic seizure?
Is it safe for a patient on aspirin, berberine, ginger, and an antacid‑aspirin product, with possible renal impairment, heart block, or severe hypotension, to start a magnesium supplement and what dosing regimen is appropriate?
What is the therapeutic serum concentration range for valproic acid in seizure treatment, and what are its side effects and required monitoring parameters?
Is buspirone (Buspar) appropriate for treating acute anxiety?
How is hypertension graded according to systolic and diastolic blood pressure levels, and what are the recommended treatment strategies for each stage?
In a 52‑year‑old patient with visual symptoms that could be due to age‑related macular degeneration, what does the ophthalmologist mean by degeneration of the crystalline lens, and how should it be evaluated and managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.